机构：[1]Hebei Univ, Affiliated Hosp, Baoding, Peoples R China河北大学附属医院[2]Hebei Gen Hosp, Shijiazhuang, Hebei, Peoples R China
出处：
ISSN：
摘要：
Introduction: Epidermal growth factor receptor (EGFR)co-mutated withTP53 could reduceresponsiveness to tyrosine kinaseinhibitors (TKIs) and worsenLUADpatients’ prognosis. Previous studies demonstrated theability ofradiomics to predict the EGFR, but fewin this unique subset through 18F-FDGPET/CT images.
第一作者机构：[1]Hebei Univ, Affiliated Hosp, Baoding, Peoples R China
推荐引用方式(GB/T 7714)：
Li Shuheng,Bian Yanzhu.Prediction of EGFR-TP53 genes co-mutations in patients with lung adenocarcinoma (LAUD) by 18F-FDG PET/CT radiomics[J].JOURNAL OF NUCLEAR MEDICINE.2024,65:
APA：
Li, Shuheng&Bian, Yanzhu.(2024).Prediction of EGFR-TP53 genes co-mutations in patients with lung adenocarcinoma (LAUD) by 18F-FDG PET/CT radiomics.JOURNAL OF NUCLEAR MEDICINE,65,
MLA：
Li, Shuheng,et al."Prediction of EGFR-TP53 genes co-mutations in patients with lung adenocarcinoma (LAUD) by 18F-FDG PET/CT radiomics".JOURNAL OF NUCLEAR MEDICINE 65.(2024)
医学